Ann Arbor, MI, United States of America

Gerald Paul Schielke


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Gerald Paul Schielke

Introduction

Gerald Paul Schielke is a notable inventor based in Ann Arbor, MI, with a significant contribution to the field of pharmaceuticals. He holds five patents that focus on innovative compounds aimed at treating various medical conditions. His work has implications for numerous diseases, showcasing his dedication to advancing medical science.

Latest Patents

One of Schielke's latest patents is centered around heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases. These compounds are particularly useful in treating conditions such as multiple sclerosis, atherosclerotic plaque rupture, and various neurodegenerative disorders. Another significant patent involves biphenyl butyric acids and their derivatives, which also serve as inhibitors of matrix metalloproteinases and are applicable in treating similar medical issues.

Career Highlights

Throughout his career, Schielke has worked with prominent companies, including Warner-Lambert Company and Warner Lambert LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Some of his notable coworkers include Claude Forsey Purchase, Jr. and Bruce D. Roth. Their collaborations have likely enriched the research and development processes in which Schielke has been involved.

Conclusion

Gerald Paul Schielke's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to innovation and improving healthcare outcomes. His work continues to influence the treatment of various diseases, highlighting the importance of research and development in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…